🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the addition of birinapant in subjects with chronic He...
Status
Terminated
Location
CMAX / Royal Adelaide Hospital
Start Date
2014-11
Trial ID
NCT02288208
Treatments Being Tested
This phase I/II trial studies how well birinapant and carboplatin work in t...
Status
Withdrawn
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2018-08-01
Trial ID
NCT02756130
Treatments Being Tested
This phase I trial studies the side effects and best dose of birinapant whe...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-09-25
Trial ID
NCT03803774
This is a dose escalation study in female subjects with relapsed ovarian ca...
Status
Completed
Location
TetraLogic research site
Start Date
2013-11
Trial ID
NCT01940172
Treatments Being Tested
This is a randomized double blind placebo controlled study of azacitidine w...
Status
Terminated
Location
Palo Verde Hematology Oncology
Start Date
2014-06
Trial ID
NCT02147873
Treatments Being Tested
This is a dose escalation safety study of birinapant (TL32711) in combinati...
Status
Completed
Location
Holy Cross Hospital
Start Date
2010-10
Trial ID
NCT01188499
Treatments Being Tested
An ascending dose study in patients with solid tumors to evaluate the safet...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2017-08-04
Trial ID
NCT02587962
Treatments Being Tested
Background: \- 18F-CP18 is a chemical designed for use in imaging studies....
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-11-30
Trial ID
NCT01766622
Treatments Being Tested
This study is a first-in-human, Phase 1a/1b, multicenter, open-label study ...
Status
Terminated
Location
Mayo Clinic
Start Date
2020-09-23
Trial ID
NCT04553692
Background: \- Birinapant is an experimental cancer treatment drug. It rem...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2012-08-15
Trial ID
NCT01681368
Treatments Being Tested